Cytosorbents Corporation (CTSO)
USD 1.0
(1.18%)
USD 1.0
(1.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 53.26 Million USD | -15.77% |
| 2022 | 63.23 Million USD | -29.36% |
| 2021 | 89.51 Million USD | -0.48% |
| 2020 | 89.95 Million USD | 228.49% |
| 2019 | 27.38 Million USD | -16.38% |
| 2018 | 32.74 Million USD | 35.86% |
| 2017 | 24.1 Million USD | 148.65% |
| 2016 | 9.69 Million USD | -13.87% |
| 2015 | 11.25 Million USD | 32.89% |
| 2014 | 8.46 Million USD | 109.33% |
| 2013 | 4.04 Million USD | 21.15% |
| 2012 | 3.33 Million USD | 57.33% |
| 2011 | 2.12 Million USD | 17.14% |
| 2010 | 1.81 Million USD | -19.06% |
| 2009 | 2.23 Million USD | -33.91% |
| 2008 | 3.38 Million USD | 322.04% |
| 2007 | 802.57 Thousand USD | -76.7% |
| 2006 | 3.44 Million USD | 11383.5% |
| 2005 | 30 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 47.07 Million USD | -11.62% |
| 2024 Q2 | 53.42 Million USD | 13.5% |
| 2023 FY | 53.26 Million USD | -15.77% |
| 2023 Q4 | 53.26 Million USD | 11.95% |
| 2023 Q3 | 47.57 Million USD | -9.29% |
| 2023 Q2 | 52.44 Million USD | -8.73% |
| 2023 Q1 | 57.46 Million USD | -9.12% |
| 2022 Q4 | 63.23 Million USD | 1.54% |
| 2022 Q1 | 83.27 Million USD | -6.98% |
| 2022 FY | 63.23 Million USD | -29.36% |
| 2022 Q2 | 71.2 Million USD | -14.49% |
| 2022 Q3 | 62.26 Million USD | -12.55% |
| 2021 Q1 | 87.47 Million USD | -2.75% |
| 2021 FY | 89.51 Million USD | -0.48% |
| 2021 Q2 | 98.19 Million USD | 12.25% |
| 2021 Q3 | 95.06 Million USD | -3.18% |
| 2021 Q4 | 89.51 Million USD | -5.84% |
| 2020 Q3 | 104.28 Million USD | 111.7% |
| 2020 FY | 89.95 Million USD | 228.49% |
| 2020 Q1 | 44.22 Million USD | 61.51% |
| 2020 Q2 | 49.25 Million USD | 11.38% |
| 2020 Q4 | 89.95 Million USD | -13.74% |
| 2019 Q4 | 27.38 Million USD | -4.53% |
| 2019 Q3 | 28.68 Million USD | 0.7% |
| 2019 Q2 | 28.48 Million USD | -8.1% |
| 2019 Q1 | 30.99 Million USD | -5.35% |
| 2019 FY | 27.38 Million USD | -16.38% |
| 2018 Q1 | 28.3 Million USD | 17.43% |
| 2018 Q3 | 34.24 Million USD | -1.99% |
| 2018 Q4 | 32.74 Million USD | -4.39% |
| 2018 FY | 32.74 Million USD | 35.86% |
| 2018 Q2 | 34.94 Million USD | 23.47% |
| 2017 Q4 | 24.1 Million USD | 8.48% |
| 2017 Q2 | 22.08 Million USD | 166.45% |
| 2017 FY | 24.1 Million USD | 148.65% |
| 2017 Q1 | 8.28 Million USD | -14.49% |
| 2017 Q3 | 22.21 Million USD | 0.6% |
| 2016 Q4 | 9.69 Million USD | -10.72% |
| 2016 FY | 9.69 Million USD | -13.87% |
| 2016 Q3 | 10.85 Million USD | -14.58% |
| 2016 Q2 | 12.71 Million USD | 33.63% |
| 2016 Q1 | 9.51 Million USD | -15.48% |
| 2015 Q4 | 11.25 Million USD | -12.09% |
| 2015 FY | 11.25 Million USD | 32.89% |
| 2015 Q1 | 15.86 Million USD | 87.33% |
| 2015 Q2 | 14.09 Million USD | -11.13% |
| 2015 Q3 | 12.8 Million USD | -9.2% |
| 2014 Q3 | 9.62 Million USD | -14.48% |
| 2014 FY | 8.46 Million USD | 109.33% |
| 2014 Q4 | 8.46 Million USD | -12.03% |
| 2014 Q1 | 12.39 Million USD | 206.32% |
| 2014 Q2 | 11.25 Million USD | -9.17% |
| 2013 Q1 | 2.52 Million USD | -24.34% |
| 2013 FY | 4.04 Million USD | 21.15% |
| 2013 Q2 | 2.98 Million USD | 17.98% |
| 2013 Q3 | 4.03 Million USD | 35.49% |
| 2013 Q4 | 4.04 Million USD | 0.17% |
| 2012 FY | 3.33 Million USD | 57.33% |
| 2012 Q1 | 2.78 Million USD | 31.17% |
| 2012 Q4 | 3.33 Million USD | 2.18% |
| 2012 Q3 | 3.26 Million USD | 12.84% |
| 2012 Q2 | 2.89 Million USD | 4.03% |
| 2011 Q4 | 2.12 Million USD | -27.67% |
| 2011 Q1 | 2.87 Million USD | 58.67% |
| 2011 Q2 | 3.86 Million USD | 34.35% |
| 2011 Q3 | 2.93 Million USD | -24.03% |
| 2011 FY | 2.12 Million USD | 17.14% |
| 2010 Q3 | 1.11 Million USD | 16.52% |
| 2010 FY | 1.81 Million USD | -19.06% |
| 2010 Q4 | 1.81 Million USD | 63.2% |
| 2010 Q1 | 1.68 Million USD | -24.59% |
| 2010 Q2 | 952.83 Thousand USD | -43.56% |
| 2009 Q4 | 2.23 Million USD | 73.83% |
| 2009 FY | 2.23 Million USD | -33.91% |
| 2009 Q2 | 1.78 Million USD | -30.04% |
| 2009 Q3 | 1.28 Million USD | -28.03% |
| 2009 Q1 | 2.55 Million USD | -24.49% |
| 2008 Q1 | 606.57 Thousand USD | -24.42% |
| 2008 Q4 | 3.38 Million USD | -12.66% |
| 2008 Q3 | 3.87 Million USD | -6.44% |
| 2008 Q2 | 4.14 Million USD | 583.41% |
| 2008 FY | 3.38 Million USD | 322.04% |
| 2007 Q2 | 2.01 Million USD | -26.68% |
| 2007 Q1 | 2.75 Million USD | -20.05% |
| 2007 FY | 802.57 Thousand USD | -76.7% |
| 2007 Q4 | 802.57 Thousand USD | -39.46% |
| 2007 Q3 | 1.32 Million USD | -34.36% |
| 2006 Q4 | 3.44 Million USD | -17.43% |
| 2006 Q3 | 4.17 Million USD | -25.19% |
| 2006 Q2 | 5.57 Million USD | 33333.86% |
| 2006 FY | 3.44 Million USD | 11383.5% |
| 2006 Q1 | 16.68 Thousand USD | -12.39% |
| 2005 Q4 | 19.04 Thousand USD | -3.02% |
| 2005 Q3 | 19.63 Thousand USD | -34.55% |
| 2005 Q1 | 30 Thousand USD | -34.9% |
| 2005 FY | 30 Thousand USD | 0.0% |
| 2005 Q2 | 30 Thousand USD | 0.0% |
| 2004 Q4 | 46.08 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -69.804% |
| BrainsWay Ltd. | 62.97 Million USD | 15.422% |
| Cerus Corporation | 197.74 Million USD | 73.066% |
| Envoy Medical, Inc. | 7.64 Million USD | -597.129% |
| electroCore, Inc. | 16.38 Million USD | -225.018% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -592.416% |
| IceCure Medical Ltd | 16.41 Million USD | -224.562% |
| Inogen, Inc. | 326.19 Million USD | 83.672% |
| OrthoPediatrics Corp. | 449.58 Million USD | 88.153% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -95.309% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -221.253% |
| MaxCyte, Inc. | 268.27 Million USD | 80.147% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -557.757% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1366.461% |
| Orthofix Medical Inc. | 925.31 Million USD | 94.244% |
| PAVmed Inc | 33.11 Million USD | -60.816% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 62.872% |
| RxSight, Inc. | 182.55 Million USD | 70.824% |
| Sight Sciences, Inc. | 166.65 Million USD | 68.041% |
| SI-BONE, Inc. | 230.42 Million USD | 76.886% |
| TELA Bio, Inc. | 78.04 Million USD | 31.759% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 78.857% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -396.371% |
| Acutus Medical, Inc. | 53.96 Million USD | 1.296% |
| Talis Biomedical Corporation | 98.34 Million USD | 45.84% |
| Spectral AI, Inc. | 10.69 Million USD | -398.135% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 75.641% |
| CVRx, Inc. | 115.22 Million USD | 53.778% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 9.206% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1609.673% |
| Bioventus Inc. | 810.91 Million USD | 93.432% |
| Venus Concept Inc. | 93.65 Million USD | 43.13% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -107.038% |
| LivaNova PLC | 2.42 Billion USD | 97.808% |
| 908 Devices Inc. | 202.98 Million USD | 73.761% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 93.385% |
| Nemaura Medical Inc. | 14.56 Million USD | -265.72% |
| NeuroPace, Inc. | 107.65 Million USD | 50.525% |
| LENSAR, Inc. | 69.58 Million USD | 23.46% |
| Apyx Medical Corporation | 79.24 Million USD | 32.786% |
| Cutera, Inc. | 346.29 Million USD | 84.62% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -26.763% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2862.215% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 80.32% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -24.846% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.592% |
| Axonics, Inc. | 719.92 Million USD | 92.602% |
| Outset Medical, Inc. | 313.8 Million USD | 83.027% |
| IRIDEX Corporation | 34.43 Million USD | -54.666% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 86.84% |
| IRadimed Corporation | 92.15 Million USD | 42.206% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -913.716% |
| INVO Bioscience, Inc. | 20.88 Million USD | -154.985% |
| Telesis Bio, Inc. | 70.41 Million USD | 24.358% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 65.438% |
| Varex Imaging Corporation | 1.24 Billion USD | 95.738% |
| Quipt Home Medical Corp. | 247.4 Million USD | 78.473% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -472.08% |
| Pulmonx Corporation | 178.95 Million USD | 70.237% |
| Dynatronics Corporation | 25.94 Million USD | -105.318% |
| Modular Medical, Inc. | 13.8 Million USD | -285.751% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -396.51% |
| Semler Scientific, Inc. | 78.06 Million USD | 31.774% |
| InMode Ltd. | 863.28 Million USD | 93.83% |
| Bruker Corporation | 4.24 Billion USD | 98.747% |
| DexCom, Inc. | 6.26 Billion USD | 99.15% |
| Align Technology, Inc. | 6.08 Billion USD | 99.125% |
| Viveve Medical, Inc. | 25.91 Million USD | -105.536% |
| ZimVie Inc. | 1.2 Billion USD | 95.581% |
| Movano Inc. | 9.42 Million USD | -465.339% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 89.298% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1366.461% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 9.206% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 94.409% |
| Profound Medical Corp. | 43.68 Million USD | -21.916% |
| Insulet Corporation | 2.58 Billion USD | 97.942% |
| enVVeno Medical Corporation | 48.63 Million USD | -9.511% |
| Surmodics, Inc. | 185.73 Million USD | 71.324% |
| iCAD, Inc. | 41.41 Million USD | -28.593% |
| Nuwellis, Inc. | 9.77 Million USD | -445.145% |
| Biotricity, Inc. | 5.94 Million USD | -796.248% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 87.704% |
| Aethlon Medical, Inc. | 8.24 Million USD | -545.898% |
| InspireMD, Inc. | 47.64 Million USD | -11.791% |
| PAVmed Inc. | 33.11 Million USD | -60.816% |
| BIOLASE, Inc. | 35.1 Million USD | -51.735% |
| Beyond Air, Inc. | 56.96 Million USD | 6.496% |
| FONAR Corporation | 214.24 Million USD | 75.14% |
| AxoGen, Inc. | 196.82 Million USD | 72.94% |
| Vivani Medical, Inc. | 45.79 Million USD | -16.297% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 81.076% |
| Inari Medical, Inc. | 674.23 Million USD | 92.101% |
| UFP Technologies, Inc. | 404.13 Million USD | 86.821% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -127.624% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -460.455% |
| Tenon Medical, Inc. | 6.34 Million USD | -739.411% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -466.181% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 48.614% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.847% |
| Sintx Technologies, Inc. | 15.36 Million USD | -246.636% |
| NanoVibronix, Inc. | 6.67 Million USD | -698.032% |
| Quanterix Corporation | 425.01 Million USD | 87.468% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -472.08% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 0.868% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 96.95% |
| TransMedics Group, Inc. | 706.04 Million USD | 92.457% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 15.716% |
| NeuroMetrix, Inc. | 21.42 Million USD | -148.598% |
| Hyperfine, Inc. | 94.19 Million USD | 43.459% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 80.174% |
| Biomerica, Inc. | 9.25 Million USD | -475.542% |
| Bone Biologics Corporation | 3.73 Million USD | -1324.933% |
| AVITA Medical, Inc. | 144.33 Million USD | 63.101% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -993.978% |
| Silk Road Medical, Inc | 265.3 Million USD | 79.925% |